Change Healthcare sets up new electronic prescription service, funding program as cyberattack drags

Change Healthcare sets up new electronic prescription service, funding program as cyberattack drags


In this photo illustration, UnitedHealth Group Inc logo seen displayed on a tablet.

Igor Golovniov | Sopa Images | Lightrocket | Getty Images

Change Healthcare on Friday said it’s finished setting up a new electronic prescription service, which could help provide some relief to pharmacies and physicians that have been struggling to contend with the fallout from the ongoing cyberattack.

UnitedHealth Group, Change Healthcare’s parent company, is also launching a temporary funding assistance program to help providers manage their “short-term” cash flow needs, the company said.

UnitedHealth discovered that a cyber threat actor breached part of the unit’s information technology network on Feb. 21, according to a filing with the SEC. UnitedHealth isolated and disconnected the impacted systems “immediately upon detection” of the threat, the filing said, which has since caused ripples of disruption across the health-care system.

Change Healthcare offers tools for payment and revenue cycle management that help carry out transactions between providers and most major insurance companies. It also offers electronic prescription software.

In an update Friday, Change Healthcare said it has successfully tested a new version of its “Rx ePrescribing service” with vendors and retail pharmacy partners. The service was enabled for all customers starting at 2 p.m. ET on Friday, though the company added that its existing Clinical Exchange ePrescribing providers’ tools are still not working.

UnitedHealth also launched a website on Friday with information about Change Healthcare’s response to the attack. On the site, UnitedHealth said it’s establishing a temporary funding assistance program to help providers whose payment distributions have been interrupted.

The company said the program will have no fees, interest or other associated costs, and the funds will need to be repaid when standard operations resume. Providers can check their eligibility using a link through the new website.

“We understand the urgency of resuming payment operations and continuing the flow of payments through the health care ecosystem,” UnitedHealth said on the site.

The company added that the program is not meant for providers that are experiencing disruptions to their claims submissions. UnitedHealth recommends using manual workarounds for claims, and said it’s working to address the 15% of claims that workarounds cannot address.

UnitedHealth said late Monday night that more than 90% of the nation’s pharmacies had set up modified electronic claims processing workarounds, while the rest established offline processing systems. On Friday, the company said its data suggests pharmacy claims are “flowing at near-normal levels,” according to the new website.

Many of the company’s systems have been down for 10 straight days.

WATCH: ‘You can’t unscramble that egg’

'You can't unscramble that egg,' top healthcare analyst reacts to DOJ's UnitedHealth antitrust probe



Source

A world on weight loss drugs: How GLP-1s are reshaping the economy
Health

A world on weight loss drugs: How GLP-1s are reshaping the economy

Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to […]

Read More
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
Health

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]

Read More
Supreme Court allows Trump’s cuts to health research grants over DEI policies
Health

Supreme Court allows Trump’s cuts to health research grants over DEI policies

The Supreme Court on Thursday allowed Trump administration broad cuts to National Institutes of Health grants as part of the federal government’s campaign against diversity, equity and inclusion policies. But in a mixed decision the court left in place a different part of the lower court judge’s ruling that threw out the administration’s guidance document that introduced the policy, […]

Read More